Literature DB >> 1957937

Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis, and subjects without pain: a blind comparison of DSM-III diagnoses.

T A Ahles1, S A Khan, M B Yunus, D A Spiegel, A T Masi.   

Abstract

OBJECTIVE: The major purpose of this study was to compare the frequency of the occurrence of DSM-III diagnoses in patients with primary fibromyalgia syndrome, patients with rheumatoid arthritis, and subjects without pain.
METHOD: Thirty-five patients with primary fibromyalgia, 33 patients with rheumatoid arthritis, and 31 nonpatients without pain were blindly assessed for psychiatric diagnoses with the Psychiatric Diagnostic Interview.
RESULTS: Data from this interview revealed no group differences in terms of lifetime history of any psychiatric disorders, including major depression, somatization disorder, or anxiety-based disorders. Analysis of the auxiliary symptoms of depression on the Psychiatric Diagnostic Interview revealed that the patients with fibromyalgia did not report a higher frequency of vegetative signs of depression. However, analysis of the somatization scale revealed an interaction between medical and psychiatric diagnoses: patients with primary fibromyalgia syndrome and a psychiatric history endorsed significantly more somatic symptoms than did patients with rheumatoid arthritis or subjects without pain, and fibromyalgia patients without a psychiatric history were no more likely to endorse somatic symptoms than were arthritis patients or subjects without pain.
CONCLUSIONS: The Psychiatric Diagnostic Interview data failed to discriminate in any major way between primary fibromyalgia syndrome (a disorder with no known organic etiology) and rheumatoid arthritis (a disorder with a known organic etiology). Therefore, these data do not support a psychopathology model as a primary explanation of the symptoms of primary fibromyalgia syndrome.

Entities:  

Mesh:

Year:  1991        PMID: 1957937     DOI: 10.1176/ajp.148.12.1721

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  19 in total

1.  Treatment of fibromyalgia with antidepressants: a meta-analysis.

Authors:  P G O'Malley; E Balden; G Tomkins; J Santoro; K Kroenke; J L Jackson
Journal:  J Gen Intern Med       Date:  2000-09       Impact factor: 5.128

2.  The development and psychometric validation of the central sensitization inventory.

Authors:  Tom G Mayer; Randy Neblett; Howard Cohen; Krista J Howard; Yun H Choi; Mark J Williams; Yoheli Perez; Robert J Gatchel
Journal:  Pain Pract       Date:  2011-09-27       Impact factor: 3.183

3.  The contribution of family cohesion and the pain-coping process to depressive symptoms in fibromyalgia.

Authors:  P M Nicassio; V Radojevic; K Schoenfeld-Smith; K Dwyer
Journal:  Ann Behav Med       Date:  1995-12

4.  Personality and Affect When the Central Nervous System is Sensitized: An Analysis of Central Sensitization Syndromes in a Substance Use Disorder Population.

Authors:  Lindsey C McKernan; Michael T M Finn; Erika R Carr
Journal:  Psychodyn Psychiatry       Date:  2017

5.  Individuals with fibromyalgia and depression: findings from a nationally representative Canadian survey.

Authors:  Esme Fuller-Thomson; Jodie Nimigon-Young; Sarah Brennenstuhl
Journal:  Rheumatol Int       Date:  2011-01-08       Impact factor: 2.631

6.  Depressed fibromyalgia patients are equipped with an emphatic competence dependent self-esteem.

Authors:  M Johnson; M L Paananen; P Rahinantti; P Hannonen
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980

7.  Psychological disturbance in fibromyalgia: relation to pain severity.

Authors:  R Celiker; P Borman; F Oktem; Y Gökçe-Kutsal; O Başgöze
Journal:  Clin Rheumatol       Date:  1997-03       Impact factor: 2.980

8.  Identification of symptom and functional domains that fibromyalgia patients would like to see improved: a cluster analysis.

Authors:  Robert M Bennett; Jon Russell; Joseph C Cappelleri; Andrew G Bushmakin; Gergana Zlateva; Alesia Sadosky
Journal:  BMC Musculoskelet Disord       Date:  2010-06-28       Impact factor: 2.362

Review 9.  Management of psychiatric comorbidity in fibromyalgia.

Authors:  Lesley M Arnold
Journal:  Curr Psychiatry Rep       Date:  2006-06       Impact factor: 5.285

Review 10.  Fibromyalgia: A Critical and Comprehensive Review.

Authors:  Andrea T Borchers; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.